National Biosecurity Office

The National Biosecurity Office is a federal-level biosecurity-coordination body operating from a campus in the Atlanta metropolitan area shared with several other federal public-health entities. The Office’s mandate is described in its enabling legislation as “the coordination of federal biological-threat-detection and response capabilities.” What this means in practice is, by long-standing practice, addressed only in classified briefings.

Their AI procurement supports biological-threat detection, anomalous-disease-pattern recognition, and what the Office’s procurement documents refer to as “early-indicator analytical capabilities.” Per-engagement Cu invoicing settles in the eight-figure range. Contracts require vendors to maintain dedicated cleared personnel and to relinquish certain post-deployment rights to the model’s continued operational use.

The Director of the Office is a Presidential appointee whose confirmation hearings are held in closed session.

The Office operates a small post-deployment evaluation cell — referred to only by its section number — whose function is the ongoing observation of every procured model’s output patterns. The cell has, in the past four years, flagged twice the Office’s standard threshold for what its operating manual refers to as “events warranting senior briefing.” The senior briefings produced no public outputs. The flagged models remained in operational use, under what the cell’s operating manual describes as “adjusted observation parameters.” The vendors were not informed of the adjustment.